Entity HEDIS Effectiveness Of Care - Behavioral Health Analysis

DescriptionThis Analytical Requirement includes measures developed by the National Committee for Quality Assurance (NCQA) and published as part of the Healthcare Effectiveness Data and Information Set (HEDIS) 2015 Volume 2 specification.

Dimensions (and sample axes of analysis):
- Time Period (Reporting Year)
- Geographic Area (Region, State)
- Plan Member (Plan, Line of Business(Medicare, Medicaid, Commercial))
- Patient (Age range, Gender, Language, Race)
- Analytical Classification (Optional - used for measures (AMM) (ADD) & (FUH))

Attributes
Adherence To Antipsychotic Medications For Individuals With Schizophrenia (SAA)Adherence To Antipsychotic Medications For Individuals With Schizophrenia (SAA)
Analytical Classification DkAnalytical Classification Dk
Antidepressant Medication Management (AMM)Antidepressant Medication Management (AMM)
Calendar DkCalendar Dk
Cardiovascular Monitoring For People With Cardiovascular Disease And Schizophrenia (SMC)Cardiovascular Monitoring For People With Cardiovascular Disease And Schizophrenia (SMC)
Diabetes Monitoring For People With Diabetes And Schizophrenia (SMD)Diabetes Monitoring For People With Diabetes And Schizophrenia (SMD)
Diabetes Screening For People With Schizophrenia Or Bipolar Disorder Who Are Using Antipsychotic Medications (SSD)Diabetes Screening For People With Schizophrenia Or Bipolar Disorder Who Are Using Antipsychotic Medications (SSD)
Follow-Up After Hospitalization For Mental Illness (FUH)Follow-Up After Hospitalization For Mental Illness (FUH)
Follow-Up Care For Children Prescribed ADHD Medication (ADD)Follow-Up Care For Children Prescribed ADHD Medication (ADD)
Geographic Area DkGeographic Area Dk
Metabolic Monitoring For Children And Adolescents On Antipsychotics (APM)Metabolic Monitoring For Children And Adolescents On Antipsychotics (APM)
Number Of Children And Adolescents (APC-d)Number Of Children And Adolescents (APC-d)
Number Of Children And Adolescents On Antipsychotics (APM-d)Number Of Children And Adolescents On Antipsychotics (APM-d)
Number Of Children And Adolescents On Antipsychotics With Metabolic Monitoring (APM-n)Number Of Children And Adolescents On Antipsychotics With Metabolic Monitoring (APM-n)
Number Of Children And Adolescents On Multiple Concurrent Antipsychotics (APC-n)Number Of Children And Adolescents On Multiple Concurrent Antipsychotics (APC-n)
Number Of Children Continuously Prescribed ADHD Medication Followed Up (ADD-n)Number Of Children Continuously Prescribed ADHD Medication Followed Up (ADD-n)
Number Of Children Newly Prescribed ADHD Medication (ADD-d)Number Of Children Newly Prescribed ADHD Medication (ADD-d)
Number Of Children Newly Prescribed ADHD Medication Followed Up Initially (ADD-n)Number Of Children Newly Prescribed ADHD Medication Followed Up Initially (ADD-n)
Number Of Individuals With Schizophrenia (SAA-d)Number Of Individuals With Schizophrenia (SAA-d)
Number Of Individuals With Schizophrenia Adhering To Antipsychotic Medications (SAA-n)Number Of Individuals With Schizophrenia Adhering To Antipsychotic Medications (SAA-n)
Number Of Members With Depression (AMM-d)Number Of Members With Depression (AMM-d)
Number Of Members With Depression Continuing Antidepressant Treatment (AMM-n)Number Of Members With Depression Continuing Antidepressant Treatment (AMM-n)
Number Of Members With Depression On Antidepressant Treatment (AMM-n)Number Of Members With Depression On Antidepressant Treatment (AMM-n)
Number Of Mental Illness Discharges (FUH-d)Number Of Mental Illness Discharges (FUH-d)
Number Of Mental Illness Discharges Followed Up Within 30 Days (FUH-n)Number Of Mental Illness Discharges Followed Up Within 30 Days (FUH-n)
Number Of Mental Illness Discharges Followed Up Within 7 Days (FUH-n)Number Of Mental Illness Discharges Followed Up Within 7 Days (FUH-n)
Number Of People With Cardiovascular Disease And Schizophrenia (SMC-d)Number Of People With Cardiovascular Disease And Schizophrenia (SMC-d)
Number Of People With Cardiovascular Disease And Schizophrenia With Cardiovascular Monitoring (SMC-n)Number Of People With Cardiovascular Disease And Schizophrenia With Cardiovascular Monitoring (SMC-n)
Number Of People With Diabetes And Schizophrenia (SMD-d)Number Of People With Diabetes And Schizophrenia (SMD-d)
Number Of People With Diabetes And Schizophrenia Monitored For Diabetes (SMD-n)Number Of People With Diabetes And Schizophrenia Monitored For Diabetes (SMD-n)
Number Of People With Schizophrenia Or Bipolar Disorder Who Are Using Antipsychotic Medications (SSD-d)Number Of People With Schizophrenia Or Bipolar Disorder Who Are Using Antipsychotic Medications (SSD-d)
Number Of People With Schizophrenia Or Bipolar Disorder Who Are Using Antipsychotic Medications Screened For Diabetes (SSD-n)Number Of People With Schizophrenia Or Bipolar Disorder Who Are Using Antipsychotic Medications Screened For Diabetes (SSD-n)
Patient DkPatient Dk
Plan Member DkPlan Member Dk
Use Of Multiple Concurrent Antipsychotics In Children And Adolescents (APC)Use Of Multiple Concurrent Antipsychotics In Children And Adolescents (APC)

Relationship
HEDIS Effectiveness Of Care - Behavioral Health Analysis_Calendar Dimension_FKHEDIS Effectiveness Of Care - Behavioral Health Analysis_Calendar Dimension_FK
HEDIS Effectiveness Of Care - Behavioral Health Analysis_Geographic Area Dimension_FKHEDIS Effectiveness Of Care - Behavioral Health Analysis_Geographic Area Dimension_FK
HEDIS Effectiveness Of Care - Behavioral Health Analysis_Plan Member Dimension_FKHEDIS Effectiveness Of Care - Behavioral Health Analysis_Plan Member Dimension_FK
HEDIS Effectiveness Of Care - Behavioral Health Analysis_Patient Dimension_FKHEDIS Effectiveness Of Care - Behavioral Health Analysis_Patient Dimension_FK
HEDIS Effectiveness Of Care - Behavioral Health Analysis_Analytical Classification_FKHEDIS Effectiveness Of Care - Behavioral Health Analysis_Analytical Classification_FK

Primary Key
HEDIS Effectiveness Of Care - Behavioral Health Analysis PKHEDIS Effectiveness Of Care - Behavioral Health Analysis PK

Dependencies
 NONE

Reverse Dependencies
 

Attribute Details

 Adherence To Antipsychotic Medications For Individuals With Schizophrenia (SAA)
DescriptionThe percentage of members 19-64 years of age during the measurement year with schizophrenia who were dispensed and remained on an antipsychotic medication for at least 80% of their treatment period.

*This CMS (Centers for Medicare & Medicaid Services) measure has been adapted for use in HEDIS.

This definition is included with the permission of the National Committee for Quality Assurance (NCQA) and is an extract from the full measure definition published by NCQA. Refer to NCQA's HEDIS vol 2 measures for the complete measure definition.

Formula: [(A/B) *100]
(see dependencies and their labels for measures used in the formula)
Data TypeStandards - Data Domains.ddm/Data Domains/Percentage [FLOAT(2)]
Is Part Of PrimaryKeyfalse
Is Requiredfalse
Is Derivedfalse
Is Surrogate Keyfalse



 Analytical Classification Dk
DescriptionA numeric surrogate key used to uniquely identify entities in the dimensional model.
Data TypeStandards - Data Domains.ddm/Data Domains/Surrogate Key Large [LONG]
Is Part Of PrimaryKeytrue
Is Requiredtrue
Is Derivedfalse
Is Surrogate Keyfalse



 Antidepressant Medication Management (AMM)
DescriptionThe percentage of members 18 years of age and older with a diagnosis of major depression and were newly treated with antidepressant medication, and who remained on an antidepressant medication treatment. Two rates are reported.
- Effective Acute Phase Treatment. The percentage of newly diagnosed and treated members who remained on an antidepressant medication for at least 84 days (12 weeks).
- Effective Continuation Phase Treatment. The percentage of newly diagnosed and treated members who remained on an antidepressant medication for at least 180 days (6 months).

This definition is included with the permission of the National Committee for Quality Assurance (NCQA) and is an extract from the full measure definition published by NCQA. Refer to NCQA's HEDIS vol 2 measures for the complete measure definition.

Formula: [((A/C) or (B/C))*100]
(see dependencies and their labels for measures used in the formula)
Data TypeStandards - Data Domains.ddm/Data Domains/Percentage [FLOAT(2)]
Is Part Of PrimaryKeyfalse
Is Requiredfalse
Is Derivedfalse
Is Surrogate Keyfalse



 Calendar Dk
DescriptionA numeric surrogate key used to uniquely identify entities in the dimensional model.
Data TypeStandards - Data Domains.ddm/Data Domains/Surrogate Key Large [LONG]
Is Part Of PrimaryKeytrue
Is Requiredtrue
Is Derivedfalse
Is Surrogate Keyfalse



 Cardiovascular Monitoring For People With Cardiovascular Disease And Schizophrenia (SMC)
DescriptionThe percentage of members 18-64 years of age with schizophrenia and cardiovascular disease, who had an LDL-C test during the measurement year.

This definition is included with the permission of the National Committee for Quality Assurance (NCQA) and is an extract from the full measure definition published by NCQA. Refer to NCQA's HEDIS vol 2 measures for the complete measure definition.

Formula: [(A/B) *100]
(see dependencies and their labels for measures used in the formula)
Data TypeStandards - Data Domains.ddm/Data Domains/Percentage [FLOAT(2)]
Is Part Of PrimaryKeyfalse
Is Requiredfalse
Is Derivedfalse
Is Surrogate Keyfalse



 Diabetes Monitoring For People With Diabetes And Schizophrenia (SMD)
DescriptionThe percentage of members 18-64 years of age with schizophrenia and diabetes, who had both an LDL-C test and an HbA1c test during the measurement year.

This definition is included with the permission of the National Committee for Quality Assurance (NCQA) and is an extract from the full measure definition published by NCQA. Refer to NCQA's HEDIS vol 2 measures for the complete measure definition.

Formula: [(A/B) *100]
(see dependencies and their labels for measures used in the formula)
Data TypeStandards - Data Domains.ddm/Data Domains/Percentage [FLOAT(2)]
Is Part Of PrimaryKeyfalse
Is Requiredfalse
Is Derivedfalse
Is Surrogate Keyfalse



 Diabetes Screening For People With Schizophrenia Or Bipolar Disorder Who Are Using Antipsychotic Medications (SSD)
DescriptionThe percentage of members 18-64 years of age with schizophrenia or bipolar disorder, who were dispensed an antipsychotic medication and had a diabetes screening test during the measurement year.

This definition is included with the permission of the National Committee for Quality Assurance (NCQA) and is an extract from the full measure definition published by NCQA. Refer to NCQA's HEDIS vol 2 measures for the complete measure definition.

Formula: [(A/B) *100]
(see dependencies and their labels for measures used in the formula)
Data TypeStandards - Data Domains.ddm/Data Domains/Percentage [FLOAT(2)]
Is Part Of PrimaryKeyfalse
Is Requiredfalse
Is Derivedfalse
Is Surrogate Keyfalse



 Follow-Up After Hospitalization For Mental Illness (FUH)
DescriptionThe percentage of discharges for members 6 years of age and older who were hospitalized for treatment of selected mental health disorders and who had an outpatient visit, an intensive outpatient encounter or partial hospitalization with a mental health practitioner. Two rates are reported:
- The percentage of discharges for which the member received follow-up within 30 days of discharge.
- The percentage of discharges for which the member received follow-up within 7 days of discharge.

This definition is included with the permission of the National Committee for Quality Assurance (NCQA) and is an extract from the full measure definition published by NCQA. Refer to NCQA's HEDIS vol 2 measures for the complete measure definition.

Formula: [((A/C) or (B/C))*100]
(see dependencies and their labels for measures used in the formula)
Data TypeStandards - Data Domains.ddm/Data Domains/Percentage [FLOAT(2)]
Is Part Of PrimaryKeyfalse
Is Requiredfalse
Is Derivedfalse
Is Surrogate Keyfalse



 Follow-Up Care For Children Prescribed ADHD Medication (ADD)
DescriptionThe percentage of children newly prescribed attention-deficit/hyperactivity disorder (ADHD) medication who had at least three follow-up care visits within a 10-month period, one of which was within 30 days of when the first ADHD medication was dispensed. Two rates are reported.
- Initiation Phase. The percentage of members 6-12 years of age as of the IPSD with an ambulatory prescription dispensed for ADHD medication, who had one follow-up visit with practitioner with prescribing authority during the 30-day Initiation Phase.
- Continuation and Maintenance (C&M) Phase. The percentage of members 6-12 years of age as of
the IPSD with an ambulatory prescription dispensed for ADHD medication, who remained on the medication for at least 210 days and who, in addition to the visit in the Initiation Phase, had at least two follow-up visits with a practitioner within 270 days (9 months) after the Initiation Phase ended.

This definition is included with the permission of the National Committee for Quality Assurance (NCQA) and is an extract from the full measure definition published by NCQA. Refer to NCQA's HEDIS vol 2 measures for the complete measure definition.

Formula: [((A/C) or (B/C))*100]
(see dependencies and their labels for measures used in the formula)
Data TypeStandards - Data Domains.ddm/Data Domains/Percentage [FLOAT(2)]
Is Part Of PrimaryKeyfalse
Is Requiredfalse
Is Derivedfalse
Is Surrogate Keyfalse



 Geographic Area Dk
DescriptionA numeric surrogate key used to uniquely identify entities in the dimensional model.
Data TypeStandards - Data Domains.ddm/Data Domains/Surrogate Key Large [LONG]
Is Part Of PrimaryKeytrue
Is Requiredtrue
Is Derivedfalse
Is Surrogate Keyfalse



 Metabolic Monitoring For Children And Adolescents On Antipsychotics (APM)
DescriptionThe percentage of children and adolescents 1–17 years of age who had two or more antipsychotic prescriptions and had metabolic testing.

This definition is included with the permission of the National Committee for Quality Assurance (NCQA) and is an extract from the full measure definition published by NCQA. Refer to NCQA's HEDIS vol 2 measures for the complete measure definition.

Formula: [(A/B) *100]
(see dependencies and their labels for measures used in the formula)
Data TypeStandards - Data Domains.ddm/Data Domains/Percentage [FLOAT(2)]
Is Part Of PrimaryKeyfalse
Is Requiredfalse
Is Derivedfalse
Is Surrogate Keyfalse



 Number Of Children And Adolescents (APC-d)
DescriptionThe number of children and adolescents 1–17 years of age.
Data TypeStandards - Data Domains.ddm/Data Domains/Count [INTEGER]
Is Part Of PrimaryKeyfalse
Is Requiredfalse
Is Derivedfalse
Is Surrogate Keyfalse



 Number Of Children And Adolescents On Antipsychotics (APM-d)
DescriptionThe number of children and adolescents 1–17 years of age who had two or more antipsychotic prescriptions.
Data TypeStandards - Data Domains.ddm/Data Domains/Count [INTEGER]
Is Part Of PrimaryKeyfalse
Is Requiredfalse
Is Derivedfalse
Is Surrogate Keyfalse



 Number Of Children And Adolescents On Antipsychotics With Metabolic Monitoring (APM-n)
DescriptionThe number of children and adolescents 1–17 years of age who had two or more antipsychotic prescriptions and had metabolic testing.
Data TypeStandards - Data Domains.ddm/Data Domains/Count [INTEGER]
Is Part Of PrimaryKeyfalse
Is Requiredfalse
Is Derivedfalse
Is Surrogate Keyfalse



 Number Of Children And Adolescents On Multiple Concurrent Antipsychotics (APC-n)
DescriptionThe number of children and adolescents 1–17 years of age who were on two or more concurrent antipsychotic medications.
Data TypeStandards - Data Domains.ddm/Data Domains/Count [INTEGER]
Is Part Of PrimaryKeyfalse
Is Requiredfalse
Is Derivedfalse
Is Surrogate Keyfalse



 Number Of Children Continuously Prescribed ADHD Medication Followed Up (ADD-n)
DescriptionThe number of children (members 6-12 years of age as of the IPSD) newly prescribed attention-deficit/hyperactivity disorder (ADHD) medication who remained on the medication for at least 210 days and who, in addition to the visit in the Initiation Phase, had at least two follow-up visits with a practitioner within 270 days (9 months) after the Initiation Phase ended.
Data TypeStandards - Data Domains.ddm/Data Domains/Count [INTEGER]
Is Part Of PrimaryKeyfalse
Is Requiredfalse
Is Derivedfalse
Is Surrogate Keyfalse



 Number Of Children Newly Prescribed ADHD Medication (ADD-d)
DescriptionThe number of children (members 6-12 years of age as of the IPSD) newly prescribed attention-deficit/hyperactivity disorder (ADHD) medication.
Data TypeStandards - Data Domains.ddm/Data Domains/Count [INTEGER]
Is Part Of PrimaryKeyfalse
Is Requiredfalse
Is Derivedfalse
Is Surrogate Keyfalse



 Number Of Children Newly Prescribed ADHD Medication Followed Up Initially (ADD-n)
DescriptionThe number of children (members 6-12 years of age as of the IPSD) newly prescribed attention-deficit/hyperactivity disorder (ADHD) medication who had one follow-up visit with practitioner with prescribing authority during the 30-day Initiation Phase.
Data TypeStandards - Data Domains.ddm/Data Domains/Count [INTEGER]
Is Part Of PrimaryKeyfalse
Is Requiredfalse
Is Derivedfalse
Is Surrogate Keyfalse



 Number Of Individuals With Schizophrenia (SAA-d)
DescriptionThe number of members 19-64 years of age during the measurement year with schizophrenia.
Data TypeStandards - Data Domains.ddm/Data Domains/Count [INTEGER]
Is Part Of PrimaryKeyfalse
Is Requiredfalse
Is Derivedfalse
Is Surrogate Keyfalse



 Number Of Individuals With Schizophrenia Adhering To Antipsychotic Medications (SAA-n)
DescriptionThe number of members 19-64 years of age during the measurement year with schizophrenia who were dispensed and remained on an antipsychotic medication for at least 80% of their treatment period.
Data TypeStandards - Data Domains.ddm/Data Domains/Count [INTEGER]
Is Part Of PrimaryKeyfalse
Is Requiredfalse
Is Derivedfalse
Is Surrogate Keyfalse



 Number Of Members With Depression (AMM-d)
DescriptionThe number of members 18 years of age and older with a diagnosis of major depression and were newly treated with antidepressant medication.
Data TypeStandards - Data Domains.ddm/Data Domains/Count [INTEGER]
Is Part Of PrimaryKeyfalse
Is Requiredfalse
Is Derivedfalse
Is Surrogate Keyfalse



 Number Of Members With Depression Continuing Antidepressant Treatment (AMM-n)
DescriptionThe number of members 18 years of age and older with a diagnosis of major depression and were newly treated with antidepressant medication, and who remained on an antidepressant medication for at least 180 days (6 months).
Data TypeStandards - Data Domains.ddm/Data Domains/Count [INTEGER]
Is Part Of PrimaryKeyfalse
Is Requiredfalse
Is Derivedfalse
Is Surrogate Keyfalse



 Number Of Members With Depression On Antidepressant Treatment (AMM-n)
DescriptionThe number of members 18 years of age and older with a diagnosis of major depression and were newly treated with antidepressant medication, and who remained on an antidepressant medication treatment for at least 84 days (12 weeks).
Data TypeStandards - Data Domains.ddm/Data Domains/Count [INTEGER]
Is Part Of PrimaryKeyfalse
Is Requiredfalse
Is Derivedfalse
Is Surrogate Keyfalse



 Number Of Mental Illness Discharges (FUH-d)
DescriptionThe number of discharges for members 6 years of age and older who were hospitalized for treatment of selected mental health disorders.
Data TypeStandards - Data Domains.ddm/Data Domains/Count [INTEGER]
Is Part Of PrimaryKeyfalse
Is Requiredfalse
Is Derivedfalse
Is Surrogate Keyfalse



 Number Of Mental Illness Discharges Followed Up Within 30 Days (FUH-n)
DescriptionThe number of discharges for members 6 years of age and older who were hospitalized for treatment of selected mental health disorders and who had an outpatient visit, an intensive outpatient encounter or partial hospitalization with a mental health practitioner within 30 days of discharge.
Data TypeStandards - Data Domains.ddm/Data Domains/Count [INTEGER]
Is Part Of PrimaryKeyfalse
Is Requiredfalse
Is Derivedfalse
Is Surrogate Keyfalse



 Number Of Mental Illness Discharges Followed Up Within 7 Days (FUH-n)
DescriptionThe number of discharges for members 6 years of age and older who were hospitalized for treatment of selected mental health disorders and who had an outpatient visit, an intensive outpatient encounter or partial hospitalization with a mental health practitioner within 7 days of discharge.
Data TypeStandards - Data Domains.ddm/Data Domains/Count [INTEGER]
Is Part Of PrimaryKeyfalse
Is Requiredfalse
Is Derivedfalse
Is Surrogate Keyfalse



 Number Of People With Cardiovascular Disease And Schizophrenia (SMC-d)
DescriptionThe number of members 18-64 years of age with schizophrenia and cardiovascular disease.
Data TypeStandards - Data Domains.ddm/Data Domains/Count [INTEGER]
Is Part Of PrimaryKeyfalse
Is Requiredfalse
Is Derivedfalse
Is Surrogate Keyfalse



 Number Of People With Cardiovascular Disease And Schizophrenia With Cardiovascular Monitoring (SMC-n)
DescriptionThe number of members 18-64 years of age with schizophrenia and cardiovascular disease, who had an LDL-C test during the measurement year.
Data TypeStandards - Data Domains.ddm/Data Domains/Count [INTEGER]
Is Part Of PrimaryKeyfalse
Is Requiredfalse
Is Derivedfalse
Is Surrogate Keyfalse



 Number Of People With Diabetes And Schizophrenia (SMD-d)
DescriptionThe number of members 18-64 years of age with schizophrenia and diabetes.
Data TypeStandards - Data Domains.ddm/Data Domains/Count [INTEGER]
Is Part Of PrimaryKeyfalse
Is Requiredfalse
Is Derivedfalse
Is Surrogate Keyfalse



 Number Of People With Diabetes And Schizophrenia Monitored For Diabetes (SMD-n)
DescriptionThe number of members 18-64 years of age with schizophrenia and diabetes, who had both an LDL-C test and an HbA1c test during the measurement year.
Data TypeStandards - Data Domains.ddm/Data Domains/Count [INTEGER]
Is Part Of PrimaryKeyfalse
Is Requiredfalse
Is Derivedfalse
Is Surrogate Keyfalse



 Number Of People With Schizophrenia Or Bipolar Disorder Who Are Using Antipsychotic Medications (SSD-d)
DescriptionThe number of members 18-64 years of age with schizophrenia or bipolar disorder, who were dispensed an antipsychotic medication.
Data TypeStandards - Data Domains.ddm/Data Domains/Count [INTEGER]
Is Part Of PrimaryKeyfalse
Is Requiredfalse
Is Derivedfalse
Is Surrogate Keyfalse



 Number Of People With Schizophrenia Or Bipolar Disorder Who Are Using Antipsychotic Medications Screened For Diabetes (SSD-n)
DescriptionThe number of members 18-64 years of age with schizophrenia or bipolar disorder, who were dispensed an antipsychotic medication and had a diabetes screening test during the measurement year.
Data TypeStandards - Data Domains.ddm/Data Domains/Count [INTEGER]
Is Part Of PrimaryKeyfalse
Is Requiredfalse
Is Derivedfalse
Is Surrogate Keyfalse



 Patient Dk
DescriptionA numeric surrogate key used to uniquely identify entities in the dimensional model.
Data TypeStandards - Data Domains.ddm/Data Domains/Surrogate Key Large [LONG]
Is Part Of PrimaryKeytrue
Is Requiredtrue
Is Derivedfalse
Is Surrogate Keyfalse



 Plan Member Dk
DescriptionA numeric surrogate key used to uniquely identify entities in the dimensional model.
Data TypeStandards - Data Domains.ddm/Data Domains/Surrogate Key Large [LONG]
Is Part Of PrimaryKeytrue
Is Requiredtrue
Is Derivedfalse
Is Surrogate Keyfalse



 Use Of Multiple Concurrent Antipsychotics In Children And Adolescents (APC)
DescriptionThe percentage of children and adolescents 1–17 years of age who were on two or more concurrent antipsychotic medications.
Note: A lower rate indicates better performance.

This definition is included with the permission of the National Committee for Quality Assurance (NCQA) and is an extract from the full measure definition published by NCQA. Refer to NCQA's HEDIS vol 2 measures for the complete measure definition.

Formula: [(A/B) *100]
(see dependencies and their labels for measures used in the formula)
Data TypeStandards - Data Domains.ddm/Data Domains/Percentage [FLOAT(2)]
Is Part Of PrimaryKeyfalse
Is Requiredfalse
Is Derivedfalse
Is Surrogate Keyfalse

Relationship Details

 HEDIS Effectiveness Of Care - Behavioral Health Analysis_Calendar Dimension_FK
Is Identifying Relationshiptrue
Child TableHEDIS Effectiveness Of Care - Behavioral Health Analysis
Child MultiplicityZERO_TO_MANY
Child Referential Integrity: On DeleteNONE
Child Referential Integrity: On InsertNONE
Child Referential Integrity: On UpdateNONE
Parent TableCalendar Dimension
Parent MultiplicityONE
Parent Referential Integrity: On DeleteNONE
Parent Referential Integrity: On InsertNONE
Parent Referential Integrity: On UpdateNONE



 HEDIS Effectiveness Of Care - Behavioral Health Analysis_Geographic Area Dimension_FK
Is Identifying Relationshiptrue
Child TableHEDIS Effectiveness Of Care - Behavioral Health Analysis
Child MultiplicityZERO_TO_MANY
Child Referential Integrity: On DeleteNONE
Child Referential Integrity: On InsertNONE
Child Referential Integrity: On UpdateNONE
Parent TableGeographic Area Dimension
Parent MultiplicityONE
Parent Referential Integrity: On DeleteNONE
Parent Referential Integrity: On InsertNONE
Parent Referential Integrity: On UpdateNONE



 HEDIS Effectiveness Of Care - Behavioral Health Analysis_Plan Member Dimension_FK
Is Identifying Relationshiptrue
Child TableHEDIS Effectiveness Of Care - Behavioral Health Analysis
Child MultiplicityZERO_TO_MANY
Child Referential Integrity: On DeleteNONE
Child Referential Integrity: On InsertNONE
Child Referential Integrity: On UpdateNONE
Parent TablePlan Member Dimension
Parent MultiplicityONE
Parent Referential Integrity: On DeleteNONE
Parent Referential Integrity: On InsertNONE
Parent Referential Integrity: On UpdateNONE



 HEDIS Effectiveness Of Care - Behavioral Health Analysis_Patient Dimension_FK
Is Identifying Relationshiptrue
Child TableHEDIS Effectiveness Of Care - Behavioral Health Analysis
Child MultiplicityZERO_TO_MANY
Child Referential Integrity: On DeleteNONE
Child Referential Integrity: On InsertNONE
Child Referential Integrity: On UpdateNONE
Parent TablePatient Dimension
Parent MultiplicityONE
Parent Referential Integrity: On DeleteNONE
Parent Referential Integrity: On InsertNONE
Parent Referential Integrity: On UpdateNONE



 HEDIS Effectiveness Of Care - Behavioral Health Analysis_Analytical Classification_FK
Is Identifying Relationshiptrue
Child TableHEDIS Effectiveness Of Care - Behavioral Health Analysis
Child MultiplicityZERO_TO_MANY
Child Referential Integrity: On DeleteNONE
Child Referential Integrity: On InsertNONE
Child Referential Integrity: On UpdateNONE
Parent TableCommon Code Dimension
Parent MultiplicityONE
Parent Referential Integrity: On DeleteNONE
Parent Referential Integrity: On InsertNONE
Parent Referential Integrity: On UpdateNONE

Primary Key Details

 HEDIS Effectiveness Of Care - Behavioral Health Analysis PK
Key AttributePlan Member Dk
Key AttributePatient Dk
Key AttributeAnalytical Classification Dk
Key AttributeCalendar Dk
Key AttributeGeographic Area Dk